Study for Patients With Non Small Cell Lung Cancer (NSCLC)

PHASE2UnknownINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

December 31, 2006

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

Carboplatin

DRUG

Paclitaxel

DRUG

Vinorelbine

Trial Locations (1)

12203

RECRUITING

Hematology & Oncology Charité CBF Berlin, Berlin

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Pierre Fabre Pharma GmbH

INDUSTRY

lead

Charite University, Berlin, Germany

OTHER